QLIFE HOLDING AB, QUARTERLY REPORT Q1 2022
TRANSITIONING TO A POST COVID REALITYFINANCIAL SUMMARY – FIRST QUARTER 2022 · Revenue in the period amounted to kSEK 10,905 (11,176). Revenue includes sales of Egoo.Health devices and capsules for the device. We saw strong sales early in the quarter and a slow down in March as testing activity in Sweden declined. · EBITDA for the period amounted to kSEK -16,295 (-3,114), and net loss kSEK -18,001 (-6,707). · The total cash flow in the first quarter amounted to kSEK -30,736 (-11,284). · Earnings per share before/after dilution for the first quarter amounted to SEK -0.99 (-0.36),